Synthetic Biology in Australia: An outlook to 2030

Synthetic biology involves the design and construction of new biological parts, devices, and systems, as well as the re-design of existing, natural biological systems for useful purposes. With early applications spanning across health care, climate change mitigation, biocontrol, agriculture and manufacturing the opportunities are significant. However, accompanying the high expectations of these technologies, there is considerable uncertainty and active debate on related social, cultural, ethical, health, economic, regulatory and legal issues.

This project will examine the opportunities and issues that synthetic biology will be likely to exert in Australia in the coming decade. 

The project is supported by CSIRO.

Expert Working Group

  • Professor Peter Gray FTSE (Chair)
  • Professor Paul Griffiths FAHA
  • Dr Sue Meek AO FTSE
  • Professor Joseph Trapani FAHMS
  • Professor Ian Small FAA
  • Associate Professor Claudia Vickers
  • Professor Catherine Waldby FASSA


additional resources

Office of the Chief Scientist: Gene Editing and CRISPR